Trial Profile

Second phase I trial to investigate two twice-daily controlled release formulations of DM-1992 (levodopa/carbidopa) compared with a sustained release generic forumation, Sinemet, in patients with Parkinson's disease.

Status: Completed

Phase of Trial: Phase I

Latest Information Update: 22 Nov 2018

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

28 Feb 2012 Results published in Clinical Neuropharmacology.
07 Feb 2011 Preliminary results have been reported in a Depomed media release. Further results are expected to be presented at an upcoming conference in 2011.
07 Feb 2011 Status changed from planning to completed.

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com